FDA Adverse Event Injury Summary report: N

EXEL 10-12ML SYR 20GX1" L-L

MDR report key: 19023036 · Received April 2, 2024

Report

Report Number
1035907-2024-00008
Event Type
Injury
Date Received
April 2, 2024
Date of Event
October 9, 2020
Report Date
March 21, 2024
Manufacturer
EXELINT INTERNATIONAL, CO.
Product Code
FMF
UDI-DI
20221262544
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

WE HAVE CHECKED THE RETAINED SAMPLES AS SOON AS BELOW COMPLAINT WAS RECEIVED, AND NO ABNORMAL WAS FOUND. THIS CAN BE FOUND IN CMP (B)(4).

Description of Event or Problem · 0

THE FOLLOWING IS A LEGACY COMPLAINT THAT WAS INVESTIGATED AND CLOSED IN 2020 BUT IS BEING RE-OPENED IN QUALIO BECAUSE THE INCIDENT SHOULD HAVE ORIGINALLY BEEN A REPORTABLE EVENT. REFERENCE CAPA-34 FOR EXPLANATION. WHILE USING THIS BRAND OF NEEDLE SYRINGE COMBO- MULTIPLE PATIENTS EXPERIENCING PHELBITIS- INFLAMMATION OF INJECTION SPOT. THEN NOTICED WHILE DRAWING DIFFERENT INJECTIONS, BLACK PARTICLES FROM THE RUBBER STOPPER IN SYRINGE FLOATING IN SOLUTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1590033 EXEL 10-12ML SYR 20GX1" L-L SYRINGE WITH NEEDLE FMF EXELINT INTERNATIONAL, CO. 26254 181114 20221262544

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other